INTRODUCTION
============

An endogenous ligand for PPARγ, 15-deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~) is a cyclopentenone prostaglandin formed via two step dehydration of prostaglandin D~2~. 15d-PGJ~2~ has been known to exert diverse biological activities such as pro-inflammatory/anti-inflammatory, carcinogenic/anti-carcinogenic, and prooxidant/anti-oxidant effects, depending on the types of cells and the concentration used \[[@ref1]\]. It has been shown that synthetic PPARγ ligands as well as 15d-PGJ~2~ can induce growth inhibition, apoptosis, and terminal differentiation of several types of cancerous and transformed cells. 15d-PGJ~2~ attenuated the capability of the MDA-MB-231 cells to induce xenograft tumors in nude mice \[[@ref2]\]. In addition, 15d-PGJ~2~ inhibits migration of breast cancer MDA-MD-231 cells and osteolytic breast cancer bone metastasis in nude mice \[[@ref2]\]. 15d-PGJ~2~ inhibits phorbol ester-induced expression of matrix metallopeptidase-9 and invasion of MCF-7 cells \[[@ref3]\]. Moreover, 15d-PGJ~2~ synergistically enhanced the anti-tumor activity of the chemotherapeutic agent doxorubicin in renal cell carcinoma \[[@ref4]\], and markedly reduced growth of murine colorectal carcinoma and HL-60 leukemia xenograft tumors \[[@ref5]\].

The anti-proliferative effects of 15d-PGJ~2~ are associated with de novo synthesis of proteins involved in regulating the cell cycle and apoptosis. 15d-PGJ~2~ inhibited c-myc, cyclin D2, and cyclin D1 expression with concomitant induction of p21^waf1^ and p27^kip1^ in various type of cancer cells \[[@ref6],[@ref7]\]. In addition, 15d-PGJ~2~ has been reported to induce apoptosis in diverse types of cancer cells, including gastric, colorectal, osteosarcoma, pancreatic, breast cancer \[[@ref5],[@ref8]-[@ref11]\]. 15d-PGJ~2~-induced apoptosis was associated with production of reactive oxygen species (ROS) \[[@ref9]\] and mediated by regulating expression levels of the Bcl-2 family member proteins, such as Bax and Bcl-2 \[[@ref8],[@ref12]\] and by downregulation of SIRT1 \[[@ref13]\].

Although 15d-PGJ~2~ was first identified as an endogenous PPARγ ligand, its biological effects are mainly achieved by PPARγ-independent mechanisms through direct interaction with diverse signaling molecules and their regulators. 15d-PGJ~2~ has a reactive a,b-unsaturated carbonyl group in the cyclopentane ring which reacts with nucleophilic cellular moiety such as cysteine and hence covalently modifies and regulates the activation of the redox proteins \[[@ref14]\]. For instance, 15d-PGJ~2~ directly binds to c-Jun at a specific cysteine residue located in the DNA binding domain of AP-1, thereby inactivating this transcription factor \[[@ref15]\]. Furthermore, it has been known that 15d-PGJ~2~ induces expression of phase II detoxification or antioxidant enzymes through Nrf2 activation, which may confer cellular defense against or adaptation to carcinogenic insult or oxidative stress \[[@ref16]\]. Also, 15d-PGJ~2~ directly inhibits NF-κB-dependent gene expression through covalent modifications of critical cysteine residues in IκB kinase (IKK) \[[@ref17],[@ref18]\] and the DNA-binding domains of NF-κB subunits \[[@ref18],[@ref19]\]. The inhibitory effect of 15d-PGJ~2~ on NF-κB signaling through thiol modification of NF-κB may contribute to anti-inflammatory and anti-proliferative effects through inhibition of target gene expression such as Bcl-2. In this study, we investigated pro-apoptotic activity of 15d-PGJ~2~ in Ha-*ras* transformed human breast epithelial cells with focus on IKKβ--NF-κB axis as a potential target.

MATERIALS AND METHODS
=====================

Materials
---------

15d-PGJ~2~ and 9,10-dihydro15d-PGJ~2~ (H2-15d-PGJ~2~) were purchased from Cayman Chemical Co. (Ann Arbor, MI, USA). Dulbecco's modified Eagle's medium (DMEM)/F-12, heat-inactivated horse serum, L-glutamine, penicillin/streptomycin/fungizone mixture were products of Gico BRL (Grand Island, NY, USA). MTT, insulin, cholera toxin, hydrocortisone, recombinant epidermal growth factor, *N*-Acetyl-L-cysteine (NAC), dithiothreitol (DTT), propidium iodide (PI), *N*-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (zVAD-FMK), and anti-actin antibody were purchased from the Sigma-Aldrich Co. (St Louis, MO, USA). 2',7'-Dichlorodihydrofluorescein diacetate (DCF-DA) was purchased from Calbiochem (San Diego, CA, USA). Annexin V-FITC staining agent was supplied by Biosciences Pharmingen (Franklin Lakes, NJ, USA). Tetramethylrhodamine ethyl ester (TMRE) was obtained from Molecular Probes, Inc. (Eugene, OR, USA). \[γ-^32^P\]ATP was the product of NEN Life Science (Boston, MA, USA). Antibodies against cleaved PARP and cleaved-caspase 3 were purchased from Cell Signaling Technology (Beverly, MA, USA). IKKβ and pp65 antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Secondary antibodies and FITC-conjugated goat anti-rabbit immunoglobulin G (IgG) were obtained from Zymed Laboratories Inc. (San Francisco, CA, USA). The protein G agarose bead was purchased from Invitrogen (Carlsbad, CA, USA). The enhanced chemiluminescence detection reagent was purchased from Amersham Co. (Arlington Heights, IL, USA). IKKβ (wild type) and its mutant construct IKKβ (C179A) were kindly provided by professor Dae Myung Jue from The Catholic University of Korea. 15d-PGJ~2~ was dissolved in dimethyl sulfoxide (DMSO) and diluted further in culture medium.

Cells culture
-------------

The MCF10A-*ras* cell line was kindly provided by Prof. Aree Moon of Duksung Women's University, Seoul, South Korea. The cells were cultured in DMEM: Nutrient Mixture-F-12 (DMEM/F-12) supplemented with 5% heat-inactivated horse serum, 10 μg/mL insulin, 100 ng/mL Cholera toxin, 0.5 mg/mL hydrocortisone, 20 ng/mL recombinant epidermal growth factor, 2 mM L-glutamine, 100 μg/mL penicillin/streptomycin/fungi zone mixture at 37°C in a 5% CO~2~ atmosphere.

Cell growth assay
-----------------

MCF10A-*ras* cells were plated at a density of 4 × 10^4^ cells in 48-well plates, and the cells were treated with different concentrations of 15d-PGJ~2~ for 24 hours. The cell viability was determined by the conventional MTT reduction assay. After treatment with 15d-PGJ~2~, the cells were treated with the MTT solution (final concentration, 0.25 mg/mL) for 2 hours at 37°C in a 5% CO~2~ atmosphere. The dark blue formazan crystals formed in intact cells were dissolved with DMSO and the absorbance was measured at 570 nm using a microplate reader. Results were expressed as the percentage of MTT reduction obtained in the treated cells, assuming that the absorbance of control cells was 100%. All samples were prepared in triplicates.

Annexin V-FITC staining
-----------------------

To quantify the percentage of cell population that are actively undergoing apoptosis, Annexin V-FITC was used according to manufacturer's protocol. Briefly, MCF10A-*ras* cells plated at a density of 2 × 10^5^ cells in 6-well plates were treated with 15d-PGJ~2~ in the presence or absence of NAC for 12 hours. Phosphatidylserine externalization was detected with FACScalibur instrument after staining with an impermeable dye Annexin V-FITC according to the instructions provided from the supplier.

Measurement of sub-diploid DNA and DNA distribution
---------------------------------------------------

MCF10A-*ras* cells were plated at a density of 2 × 10^5^ cells in 6-well plates, and the cells were treated with 15d-PGJ~2~ in the presence or absence of NAC for 12 hours. Adherent and detached cells were washed, trypsinized, collected by centrifuged at 1,300 rpm for 5 minutes, and fixed with 1 mL of 70% cold ethanol. Fixed cells were stored at --20°C until use it. After centrifuge at 2,100 rpm for 10 minutes, the fixed cells were stained with PBS containing 0.1% Triton X-100, 0.1 mM EDTA (pH 7.4), 10 μg/mL RNase A, 50 μg/mL PI and 10,000 cells per sample were analyzed by a FACScalibur instrument (BD Biosciences, San Jose, CA, USA) as described previously \[[@ref20]\]. The DNA histograms were further analyzed by Cell Quest Pro Software to calculate the proportion of sub-diploid cell population.

Measurement of mitochondrial transmembrane potential
----------------------------------------------------

To measure the mitochondrial transmembrane potential (Δψ~m~), the lipophilic cationic probe TMRE was used. MCF10A-*ras* cells were cultured in 4 chamber slide glasses. After treatment, the cells were rinsed with PBS and incubated with TMRE (150 nM) in the fresh media for 30 minutes at 37°C. The cells were examined under a confocal microscope (Leica Microsystems Heidelberg GmbH, Heidelberg, Germany) with the fluorescence excitation at 488 nm and emission at 590 nm.

Measurement of intracellular ROS accumulation
---------------------------------------------

To monitor net intracellular accumulation of ROS, the fluorescence generating probe DCF-DA was used. MCF10A-*ras* cells were cultured in 4 chamber slide glasses. After treatment with 15d-PGJ~2~ (10 μM) or vehicle at 37°C for 12 hours, the cells were washed with PBS and incubated with DCF-DA (10 μM) in a fresh medium for additional 15 minutes in the dark. The cells were examined under a confocal microscope (Leica Microsystems Heidelberg GmbH) with the fluorescence excitation at 488 nm and emission at 530 nm. The integrated density of 3 captured scenes of each treatment was measured using the Adobe Photoshop CS5 program (Adobe Inc., San Jose, CA, USA).

Transient transfection
----------------------

MCF10A-*ras* cells seeded at a density of 2 × 10^5^/well in a 6-well dish were grown to 60%-70% confluence in complete growth media. The cells were transfected with 2 μg of pFlag-CMV2-IKKβ (wild type) or its mutant construct IKKβ (C179A) using DOTAP liposomal transfection reagent (Roche Applied Science, Mannheim, Germany) according to the manufacturer's instructions. After 12-hour transfection, the cells were treated with 15d-PGJ~2~ or DMSO in the presence or absence of DTT for additional 12 hours and then washed with PBS and digested with lysis buffer (Promega, Madison, WI, USA) for Western blot analysis and the kinase assay.

IKK kinase assay
----------------

MCF10A-*ras* cells were cultured in 100-mm dishes in the absence or presence of 15d-PGJ~2~. When necessary, DTT (500 μM) was added. The protein was isolated as described above for the Western blot analysis. The lysed cell extract (200 μg) was precleared using normal mouse immunoglobulin G and protein G agarose beads and subjected to immunoprecipitation by using anti-IKKβ antibody. The resulting immunocomplex was pulled down by mixing with protein G agarose beads. The immunoprecipitates were suspended in 50 μL of a reaction mixture containing 1X kinase buffer (Cell Signaling Technology, Beverly, MA, USA), 1 μg glutathione S-transferase-IκBα as a substrate and 10 μCi of \[γ-^32^P\]ATP and incubated at 30°C for 45 minutes. The kinase reaction was terminated by adding SDS loading dye, boiled for 5 minutes at 99°C, vortexed and centrifuged at 5,000 rpm for 2 minutes. The supernatant was separated by 12% SDS-polyacrylamide gel. The gel was stained with Commassie Brilliant Blue G 250 and treated with destaining solution (glacial acetic acid:methanol:distilled water, 1 : 4 : 5, v/v). The destained gel was dried at 80°C for 1 hour and exposed to X-ray film to detect the phosphorylated glutathione S-transferase-IκBα in the radiogram. Mouse immunoglobulin G heavy chain band that appeared on the destained gel was used as the loading control to ensure the equal lane loading.

Electrophoretic mobility shifty assay (EMSA)
--------------------------------------------

MCF10A-*ras* cells were cultured in 100-mm dishes in the absence or presence of 15d-PGJ~2~. Nuclear extracts from the cells were prepared as described previously \[[@ref20]\]. The synthetic double strand oligonucleotide harboring the NF-κB binding domain was labeled with \[γ-^32^P\]ATP using T4 polynucleotide kinase (Takara Korea Biomedical Inc., Daejeon, Korea) and purified by gel filtration using a nick spin column (Amersham Bioscience, Piscataway, NJ, USA). To ensure the specificity of the binding, a competition experiment was carried out by adding the excess unlabeled oligonucleotide to the reaction mixture prior to the labeled oligonucleotide. After determination of the protein concentration, DNA binding reaction for EMSA was processed according to the method previously reported \[[@ref20]\].

Immunocytochemistry
-------------------

MCF10A-*ras* cells were seeded at 3 × 10^4^ cells per well in an 8 chamber slide. After fixation with 10% neutral-buffered formalin solution for 30 minutes at room temperature, MCF10A-*ras* cells were incubated with blocking agents (0.1% Tween-20 in PBS containing 5% bovine serum albumin \[BSA\]), washed with PBS and then incubated with a diluted (1 : 100) primary antibody for overnight at 4°C. After washing with PBS (twice for 5 minutes each), samples were incubated with a diluted (1 : 1,000) FITC-goat anti-rabbit IgG secondary antibody for 1 hour. This was followed by washing cells with PBS and incubation with PI. The signals were detected using a confocal microscope.

Western blot analysis
---------------------

Treated MCF10A-*ras* cells were washed with cold PBS and digested with lysis buffer (150 mM NaCl, 0.5% Triton X-100, 50 mM Tris-HCl, pH 7.4, 25 mM NaF, 20 mM EGTA, 1 mM DTT, 1 mM Na~3~VO~4~, protease inhibitor cocktail tablet) for 15 minutes on ice followed by centrifugation at 12,000 ×g for 20 minutes. The protein concentration of the supernatant was measured by using the bicinchoninic acid reagents (Pierce, Rockfold, IL, USA). Protein (30 μg) was separated by running through 12% SDS-PAGE gel and transferred to the polyvinylidene fluoride membrane (Gelman Laboratory, Ann Arbor, MI, USA). The blots were blocked with 5% non-fat dry milk-PBS containing 0.1% Tween-20 (PBST) buffer for 1 hour at room temperature. Each membrane was incubated with corresponding primary antibodies in 3% non-fat dry milk-PBST or 3% BSA. Equal protein loading was assessed using actin. After three time rinse with PBST buffer, the blot was incubated with 1 : 5,000 dilution of the horseradish peroxidase conjugated-secondary antibody (Zymed Laboratories Inc.) for 1 hour. Immunoreactive protein complexes were detected by enhanced chemiluminescence detection reagent after washing the blot three times with PBST.

Statistical analysis
--------------------

Values were expressed as the mean ± SE of at least three independent experiments. Statistical significance was determined by Student's t-test. The criterion for statistical significance was *P* \< 0.05, *P* \< 0.01, and *P* \< 0.001.

RESULTS
=======

15d-PGJ~2~ induces apoptosis in MCF10A-*ras* cells
--------------------------------------------------

First, we determined the effect of 15d-PGJ~2~ on viability of MCF10A-*ras* cells by the MTT assay. When MCF10A-*ras* cells were treated with 10 μM 15d-PGJ~2~ for 24 hours, there was about 60% reduction in the cell viability ([Fig. 1A](#F1){ref-type="fig"}). To determine whether the anti-proliferative effect of 15d-PGJ~2~ was associated with apoptotic cell death, we measured cleavage-PARP, a hallmark of apoptosis. The proteolytic cleavage of PARP was evident in the MCF10A-*ras* cells treated with 15d-PGJ~2~ ([Fig. 1B](#F1){ref-type="fig"}). To determine whether 15d-PGJ~2~-induced apoptosis was mediated by caspases, MCF10A-*ras* cells were co-treated with a pan-caspase inhibitor, zVAD-FMK. 15d-PGJ~2~-induced proteolytic cleavage of caspase-3 and its substrate PARP was attenuated by zVAD-FMK treatment ([Fig. 1C](#F1){ref-type="fig"}).

15d-PGJ~2~ induces intracellular ROS accumulation in MCF10A-*ras* cells
-----------------------------------------------------------------------

ROS is an universal entity mediating apoptosis in cancer cells \[[@ref21]\]. To determine whether 15d-PGJ~2~-induced apoptosis was attributable to generation of ROS, we utilized a fluorescent dye DCF-DA, capable of detecting peroxides including H~2~O~2~. 15d-PGJ~2~ treatment led to an enhanced accumulation of ROS, which was attenuated by the general antioxidant NAC ([Fig. 2A](#F2){ref-type="fig"}). NAC treatment attenuated 15d-PGJ~2~-induced cytotoxicity ([Fig. 2B](#F2){ref-type="fig"}), the proportion of sub-G~0~/G~1~ population ([Fig. 2C](#F2){ref-type="fig"}) and apoptotic cells stained with Annexin-V/FITC ([Fig. 2D](#F2){ref-type="fig"}). ROS generation is mediated by perturbation of mitochondrial membrane potential \[[@ref22]\]. When MCF10A-*ras* cells were exposed to 15d-PGJ~2~ (10 μM), the mitochondrial membrane became rapidly depolarized ([Fig. 2E](#F2){ref-type="fig"}). Furthermore, proteolytic cleavage of caspase-3 and its substrate PARP induced by 15d-PGJ~2~ was abrogated by NAC treatment in MCF10A-*ras* cells ([Fig. 2F](#F2){ref-type="fig"}).

15d-PGJ~2~-induced apoptosis is mediated through suppression of IKKβ
--------------------------------------------------------------------

NF-κB has been known to be associated with resistance to apoptosis in various cancer cells \[[@ref23]\]. 15d-PGJ~2~ has been known to inhibit the NF-κB signaling \[[@ref17]\]. The predominant form of NF-κB consists of p50 and p65 subunits that is sequestered in the cytoplasm by its inhibitory counterpart IκB-a. Signal dependent activation of IKK complex leads to the inducible phosphorylation of IκB proteins at two conserved serine residues located within their *N*-terminal region. Phospho-IκB proteins are ubiquitinated and subsequently degraded by the 26S proteasomes, leading to release of NF-κB from their inhibitory influence for translocation into the nucleus and transcriptional regulation of target genes, including Bcl-2.

IKK is a multi-subunit complex that contains two catalytic subunits, IKKα and IKKβ, and a regulatory subunit, IKKγ/NEMO (NF-κB essential modulator) \[[@ref24]\]. Downregulation of IKKβ is associated with suppression of tumor development \[[@ref25]\]. Therefore, targeting NF-κB and its activating kinase, IKK have become an appealing therapeutic strategy in the progression of many diseases including chronic inflammation and cancer \[[@ref26]\].

To determine whether the 15d-PGJ~2~-induced apoptosis was mediated by targeting the NF-κB pathway, we examined the effect of 15d-PGJ~2~ on DNA binding activity of NF-κB. As shown in [Figure 3A](#F3){ref-type="fig"}, 15d-PGJ~2~ inhibited the NF-κB DNA binding activity. Phosphorylation of the p65 subunit has been considered to facilitate the translocation of NF-κB into nucleus. 15d-PGJ~2~ treatment suppressed the localization of phospho-p65 into the nucleus which was blunted by co-treatment with NAC ([Fig. 3B](#F3){ref-type="fig"}).

In addition, 15d-PGJ~2~ inhibited the expression and catalytic activity of IKKβ, which were attenuated by NAC and DTT, respectively ([Fig. 4A and 4B](#F4){ref-type="fig"}). IKKβ has a cysteine residue at position 179 within its activation loop \[[@ref17]\]. To determine whether this cysteine of IKKβ is critical for loss of its catalytic activity and subsequent induction of apoptosis by 15d-PGJ~2~, we utilized a mutant IKKβ construct in which cysteine 179 is replaced by alanine. 15d-PGJ~2~-induced suppression of IKKβ catalytic activity and proteolytic cleavage of PARP were less prominent in MCF10A-*ras* cells transfected with mutant IKKβ compared to those in cells harboring wild type IKKβ ([Fig. 4C](#F4){ref-type="fig"}). These results suggest that 15d-PGJ~2~-induced apoptosis is associated, in part, with inhibition of IKKβ through covalent modification at cysteine 179. To further verify that 15d-PGJ~2~ could directly modify IKKβ, we utilized a biotinylated derivative of 15d-PGJ~2~. In this experiment, MCF10A-*ras* cells were treated with biotinylated 15d-PGJ~2~ and immunoprecipitated with anti-IKKβ, and the 15d-PGJ~2~ bound to IKKβ was detected with horseradish peroxidase (HRP)-streptavidin. We have observed that biotinylated 15d-PGJ~2~ directly bound to IKKβ, suggesting IKKβ as a critical potential target for 15d-PGJ~2~-induced apoptosis ([Fig. 4D](#F4){ref-type="fig"}).

In another experiment, a pharmacological inhibitor of IKKβ (Bay11-7082) increased the apoptotic cell population positive for Annexin V and proteolytic cleavage of caspase-3, which were suppressed by NAC treatment ([Fig. 5A and 5B](#F5){ref-type="fig"}). Moreover, the pharmacologic inhibition of IKKβ suppressed the cell viability ([Fig. 5C](#F5){ref-type="fig"}) as well as its catalytic activity ([Fig. 5D](#F5){ref-type="fig"}), which were attenuated by NAC ([Fig. 5C and 5D](#F5){ref-type="fig"}).

The α,β-unsaturated carbonyl moiety of 15d-PGJ~2~ is essential for its induction of apoptosis in MCF10A-*ras* cells
-------------------------------------------------------------------------------------------------------------------

The α,β-unsaturated carbonyl group in the cyclopentane ring of 15d-PGJ~2~ renders it reactive towards cellular nucleophilics to form covalently bound Michael adducts. To determine whether the α,β-unsaturated carbonyl moiety of 15d-PGJ~2~ plays an important role in induction of apoptosis in MCF10A-*ras* cells, we compared its effects with those of the non-electrophilic analogue, 9,10-dihydro-15d-PGJ~2~ ([Fig. 6A](#F6){ref-type="fig"}). We observed that 9,10-dihydro-15d-PGJ~2~, lacking the α,β-unsaturated carbonyl moiety, failed to generate ROS ([Fig. 6B](#F6){ref-type="fig"}) and to inhibit NF-κB DNA binding activity ([Fig. 6C](#F6){ref-type="fig"}). In addition, 9,10-dihydro-15d-PGJ~2~ did not enhance the proportions of sub-G~0~/G~1~ population and Annexin V positive cells as well as cytotoxicity in MCF10A-*ras* cells ([Fig. 6D and 6E](#F6){ref-type="fig"}). Moreover, 9,10-dihydro-15d-PGJ~2~ failed to suppress expression of IKKβ and to induce proteolytic cleavage of caspase-7 and PARP ([Fig. 6F](#F6){ref-type="fig"}). These findings suggested that the C-9 position of 15d-PGJ~2~ constituting the electrophilic α,β-unsaturated carbonyl group is essential for its pro-apoptotic activity.

DISCUSSION
==========

We observed that 15d-PGJ~2~ (10 μM) induced apoptosis in ras oncogene transformed human breast epithelial MCF10A cells, which was attributable to the ROS-mediated inhibition of catalytic activity of IKKβ and subsequently NF-κB signaling. 15d-PGJ~2~ is characterized by the presence of a reactive a,β-unsaturated carbonyl group in the cyclopentenone ring. This moiety has been known to bind to sulfhydryl groups of cysteine residues of proteins by Michael addition, resulting in alteration of the protein structure and function \[[@ref14]\]. 15d-PGJ~2~ has been reported to direct modify the Cys 179 of IKKβ within their activation loop, thereby suppressing catalytic activity of IKK and transcriptional activity of NF-κB \[[@ref17]\]. Consistent with this result, we observed that 15d-PGJ~2~-induced suppression of catalytic activity of IKKβ and proteolytic cleavage of caspase 3 were attenuated in the MCF10A-*ras* cells harboring the mutant construct in which Cys 179 is replaced by alanine. In addition, the thiol reducing agent DTT attenuated the 15d-PGJ~2~-induced suppression of IKK catalytic activity. Moreover, 9,10-dihydro-15d-PGJ~2~ failed to induction of apoptosis and proteolytic cleavage of caspase-7 and PARP as well as DNA binding activity of NF-κB. Furthermore, we have observed that biotin-conjugated 15d-PGJ~2~ directly binds to IKKβ. In line with our finding, Ciucci et al. \[[@ref27]\] have shown that 15d-PGJ~2~ inhibits the constitutive IKK and NF-κB activities in paclitaxel and doxorubicin-resistant estrogen receptor-negative breast cancer cells. 15d-PGJ~2~-induced inactivation of NF-κB was followed by downregulation of NF-κB-dependent anti-apoptotic proteins, such as cIAPs1/2, Bcl-xL, and cellular FLICE-inhibitory protein, leading to caspase activation and induction of apoptosis \[[@ref27]\]. In addition, Withaferin A from the Ayurvedic plant *Withania somnifera* has been known to directly inhibit IKKβ catalytic activity through modification of Cys 179, thereby exerting their chemotherapeutic activities \[[@ref22]\]. 15d-PGJ~2~ has been known to inhibit DNA binding of NF-κB by direct modification of Cys-62 of p50 \[[@ref19]\]. Beside these residues of Cys, modification of Cys38 of p65 also plays an important role in suppression of NF-κB signaling and induction of apoptosis \[[@ref28]\].

However, phosphorylation is critical mechanism to regulate NF-κB activation. Phosphorylation of two sites at the activation loop of IKKβ was essential for activation of IKK by tumor necrosis factor and interleukin-1 \[[@ref29]\]. Oxidation or chemical modification of the thiols in the IKKβ and NF-κB can result in a conformational change and thus affection the phosphorylation. Thiol modification of IKKβ may induce its conformational change, which may prevent upstream kinase from phosphorylating the serine residues, thereby preventing activation of the complex \[[@ref30]\]. Therefore, thiol modification of Cys179 of IKKβ can indirectly inhibit its kinase activity, resulting in suppression of NF-κB signaling.

We observed that ROS plays an important role in induction of apoptosis and nuclear translocation of p-p65 as well as suppression of IKKβ. Intracellular events associated with generation of ROS by 15d-PGJ~2~ are likely to be a consequence of depletion of reduced glutathione and glutathione peroxidase and increased production of protein--bound lipid peroxidation products (e.g., 4-hydroxy-2-nonenal and acrolein) \[[@ref31],[@ref32]\]. In addition, 15d-PGJ~2~-inducd ROS generation is associated with reduction of thioredoxin (Trx) which plays an important role in the redox regulation of signal transduction and in cytoprotection against oxidative stress \[[@ref33]\]. The overexpression of Trx protected against 15d-PGJ~2~-induced apoptosis in human neuroblastoma SH-SY5Y cells. Further, 15d-PGJ~2~ directly binds and modifies the Cys residues of Trx \[[@ref33]\]. Consistent with these results, 9,10-dihydro-15d-PGJ~2~ did not affect modification of Cys in Trx and inhibit the expression of epidermal growth factor receptor in oral squamous cell carcinoma \[[@ref25]\]. Based on the previous studies, 15d-PGJ~2~-induced disruption of mitochondrial membrane potential is attributed to disruption of redox homeostasis in MCF10A-*ras* cells.

In conclusion, 15d-PGJ~2~ inhibited IKKβ activity, thereby inactivating NF-κB signaling in MCF10A-*ras* cells. 15d-PGJ~2~-induced inhibition of NF-κB signaling and induction of apoptosis appear to be mediated by ROS and its covalent modification of IKKβ ([Fig. 7](#F7){ref-type="fig"}).
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![15-Deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~) induced apoptosis in MCF10A-*ras* cells.\
(A, B) MCF10A-*ras* cells were treated with 15d-PGJ~2~ (5 and 10 μM) for 24 hours. The cell viability was determined by the conventional MTT reduction assay. Bars represent mean ± SE of three experiments. A significant difference in the relative viability between treated cells and the solvent control is indicated with *P* \< 0.01. (B) The proteolytic cleavage of PARP and actin were examined by Western blot analysis. (C) MCF10A-*ras* cells were treated with 15d-PGJ~2~ (10 μM) for 24 hours in the presence or absence of an pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (ZVAD-FMK). Expression of cleaved PARP and caspase-3 was detected by Western blot analysis.](JCP-25-100-f1){#F1}

![Reactive oxygen species (ROS) plays an important role in induction of apoptosis by 15-deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~) in MCF10A-*ras* cells.\
MCF10A-*ras* cells were treated with 15d-PGJ~2~ (10 μM) in the presence or absence of *N*-acetyl-L-cysteine (NAC) (5 mM) for 24 hours. (A) ROS production was determined by the 2',7'-Dichlorodihydrofluorescein diacetate staining. (B) Effects of NAC (5 mM) on 15d-PGJ~2~-induced cytotoxicity was measured by the MTT assay. Bars represent mean ± SE of three independent assays. A significant difference in the relative viability between treated cells and the solvent control is indicated with *P* \< 0.01. (C, D) The sub-G~0~/G~1~ population and the Annexin V-FITC/propidium iodide positive cell population were analyzed by flow cytometry. The values in each panel indicate the ratio of apoptotic cell population. (E) Mitochondrial membrane potential was determined by use of tetramethylrhodamine ethyl ester in the cells treated with 15d-PGJ~2~ in the absence or presence of NAC (5 mM) for 24 hours. The cells were examined under a confocal microscope with the fluorescence excitation at 488 nm and emission at 590 nm. (F) Effect of NAC on 15d-PGJ~2~-induced proteolytic cleavage of PARP and caspase-3.](JCP-25-100-f2){#F2}

![15-Deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~) suppresses the NF-κB DNA binding activity.\
(A) MCF10A-*ras* cells were treated with 15d-PGJ~2~ (10 μM) for indicated time, and the nuclear protein was isolated. Nuclear extracts from MCF10A-*ras* cells were incubated with \[γ-^32^P\]-labeled oligonucleotides harboring the NF-κB-consensus sequence. (B) MCF10A-*ras* cells were treated with 15d-PGJ~2~ in the absence or presence of *N*-acetyl-L-cysteine (NAC) (5 mM) for 12 hours and immunocytochemical analysis was performed by using an antibody for phospho-p65. Propidium iodide (PI) was used to stain the nuclear of MCF10A-*ras* cells. The stained cells were analyzed under a confocal microscope.](JCP-25-100-f3){#F3}

![Downregulation of IKKβ is associated with induction of apoptosis in MCF10A-*ras* cells treated with 15-deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~).\
(A, B) MCF10A-*ras* cells were cotreated with *N*-acetyl-L-cysteine (NAC) (5 mM) or a thiol reducing agent, dithiothreitol (DTT) (500 μM), in the presence of 15d-PGJ~2~ (10 μM) for 24 hours. The expression level of IKKβ was determined by Western blot analysis. The proteins were immunoprecipitated by anti-IKKβ and subsequently incubated with glutathione S-transferase-IκB-a and \[γ-^32^P\]ATP for the kinase assay. Murine immunoglobulin G heavy chain band was used to ensure the equal lane loading. (C) MCF10A-*ras* cells were transfected with IKKβ and its mutant construct in which Cys179 is replaced by alanine. The catalytic activity of IKKβ and proteolytic cleavage of caspase-3 were determined by the kinase assay and Western blot analysis, respectively. (D) MCF10A-*ras* cells were treated with biotinylated 15d-PGJ~2~ (10 μM) for 12 hours. The biotinylated 15d-PGJ~2~-IKKβ complex was detected by the immunoprecipitation with IKKβ followed by Western blot analysis against horseradish peroxidase (HRP)-streptavidin as described in Materials and Methods.](JCP-25-100-f4){#F4}

![The IκB kinase (IKK) inhibitor Bay11-7082 induces apoptosis in MCF10A-*ras* cells.\
(A) MCF10A-*ras* cells were treated with Bay11-7082 (5 μM) for 24 hours in the absence or presence of *N*-acetyl-L-cysteine (NAC) (5 mM) to measure the Annexin V-FITC/propidium iodide positive cell population by flow cytometry. (B) MCF10A-*ras* cells were treated with the same IKK inhibitor for 24 hours, and the level of proteolytic cleavage of caspase-3 was determined by Western blot analysis. Actin was used as an equal loading control. (C) MCF10A-*ras* cells were treated with the IKK inhibitor in the absence or presence of NAC for 24 hours and cytotoxicity was measured by the MTT assay. (D). MCF10A-*ras* cells were treated with the IKK inhibitor for 12 hours, and the catalytic activity of IKK was determined by the kinase assay as described in Materials and Methods.](JCP-25-100-f5){#F5}

![The cyclopentenone ring on 15-deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~) is critical for 15d-PGJ~2~-induced apoptosis in MCF10A-*ras* cells.\
(A) The chemical structures of 15d-PGJ~2~ and its non-electrophilic 9,10-dihydro-15d-PGJ~2~. An asterisk indicates an electrophilic carbon. (B, C) MCF10A-*ras* cells were treated with 15d-PGJ~2~ (10 μM) or 9,10-dihydro-15d-PGJ~2~ (10 μM) for 24 hours. Reactive oxygen species was measured by 2',7'-Dichlorodihydrofluorescein diacetate staining. (C) Nuclear extracts from MCF10A-*ras* cells were incubated with \[γ-^32^P\]-labeled oligonucleotides harboring the NF-κB consensus sequence. The DNA binding activity were measured by electrophoretic mobility shifty assay. (D) MCF10A-*ras* cells were treated with 15d-PGJ~2~ (10 μM) or 9,10-dihydro-15d-PGJ~2~ (10 μM) for 24 hours, and cytotoxicity was measured by the MTT assay. Bars represent mean ± SE of three independent assays. A significant difference in the relative viability between treated cells and the solvent control is indicated with *P* \< 0.01. (E) MCF10A-*ras* cells were treated with dimethyl sulfoxide, 15d-PGJ~2~ (10 μM), or 9,10-dihydro-15d-PGJ~2~ (10 μM) for 24 hours to measure the sub-G~0~/G~1~ population and the Annexin V-FITC/propidium iodide positive cell population. (F) The expression of proteolytic cleavage products of caspase-7 and PARP and that of IKKβ was determined by Western blot analysis in the MCF10A-*ras* cells treated for 24 hours with 15d-PGJ~2~ (10 μM) or 9,10-dihydro-15d-PGJ~2~ (10 μM).](JCP-25-100-f6){#F6}

![Proposed scheme on 15-deoxy-Δ^12,14^-prostaglandin J~2~ (15d-PGJ~2~)-induced suppression of IκB kinase β IKKβ--NF-κB signaling in MCF10A-*ras* cells.](JCP-25-100-f7){#F7}
